ArticleMolecular cancer therapeutics2017

Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.

Casey G Langdon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.